青蒿素与牛病毒性腹泻病毒NS5B蛋白的分子对接预测及其抗病毒作用

doi:10.16431/j.cnki.1671-7236.2022.09.032

摘要/Abstract

摘要： 【目的】采用分子对接以及体外试验确定青蒿素对牛病毒性腹泻病毒（Bovine viral diarrhea virus，BVDV）复制的抑制作用，为抗病毒药物和制剂开发提供新思路。【方法】以BVDV-NS5B蛋白为作用靶点，通过PDB数据库检索蛋白三维晶体结构，并对其结构进行适当修饰处理；检索TCMSP数据库中的青蒿素结构，应用Autodock软件将两者进行分子对接及结合能打分。随后采用CCK-8试剂盒测定青蒿素对MDBK细胞的最大安全浓度；将选定浓度的青蒿素进行梯度稀释，采用先加病毒后加药物、先加药物后加病毒、中药和病毒同时作用的3种不同加药方式进行药物抗病毒试验，确定对病毒的最佳药物抑制浓度、预防浓度和杀灭浓度。应用实时荧光定量PCR法检测3种药物作用方式下BVDV的拷贝数，进一步明确药物对BVDV复制的作用。【结果】分子对接数据表明青蒿素与BVDV-NS5B存在相互作用，结合自由能为-28.6748 kJ/mol。青蒿素在MDBK细胞上的最佳药物安全浓度为100 μmol/L。3种作用方式下青蒿素浓度为100 μmol/L时均可有效影响BVDV的复制，青蒿素对BVDV的抑制作用最为明显。【结论】青蒿素可与BVDV-NS5B蛋白靶点互作，并能在MDBK细胞上有效抑制BVDV的复制，本研究为抗BVDV中药筛选奠定了基础。

关键词: 青蒿素; 牛病毒性腹泻病毒(BVDV); 抗病毒活性; 分子对接; 病毒复制

Abstract: 【Objective】 The study was aimed to determine the inhibitory effect of artemisinin on Bovine viral diarrhea virus (BVDV) replication using molecular docking as well as in vitro tests, and provide new ideas for antiviral drug and formulation development.【Method】 BVDV-NS5B protein was used as the target, and the three-dimensional crystal structure of BVDV-NS5B protein was retrieved through the PDB database, and the structure was appropriately modified.The structure of artemisinin from TCMSP database was retrieved, and Autodock software was applied to perform molecular docking and score the binding energy.The maximum safe concentration of artemisinin for MDBK cells was subsequently determined using a CCK-8 kit.The selected concentrations of artemisinin were subjected to gradient dilution, and three different ways of spiking drugs, including adding virus before adding drug, adding drug before adding virus, and the simultaneous action of traditional Chinese medicine and virus, were used for drug antiviral test to determine the optimal drug inhibitory concentration, prophylactic concentration and killing concentration against virus.Real-time quantitative PCR was used to measure the copy number of BVDV under the three modes of drug action to further define the effect of drugs on BVDV replication.【Result】 Molecular docking data indicated that artemisinin interacted with BVDV-NS5B with a binding free energy of -28.6748 kJ/mol.The optimal drug safety concentration of artemisinin on MDBK cells was 100 μmol/L.The three modes of action could effectively affect the replication of BVDV, and artemisinin had the most obvious inhibitory effect on BVDV.【Conclusion】 Artemisinin could interact with the NS5B protein target of BVDV, and could effectively inhibit the replication of BVDV in MDBK cells.This study laid a foundation for the screening of anti BVDV traditional Chinese medicine.

Key words: artemisinin; Bovine viral diarrhea virus (BVDV); antiviral activity; molecular docking; virus replication

中图分类号:

S859.3

邵百卉, 姜东君, 谢艺萌, 刘思雨, 邵子益, 张泽财, 计红, 朱战波. 青蒿素与牛病毒性腹泻病毒NS5B蛋白的分子对接预测及其抗病毒作用[J]. 中国畜牧兽医, 2022, 49(9): 3581-3588.

SHAO Baihui, JIANG Dongjun, XIE Yimeng, LIU Siyu, SHAO Ziyi, ZHANG Zecai, JI Hong, ZHU Zhanbo. Molecular Docking Prediction of Artemisinin and NS5B Protein of Bovine Viral Diarrhea Virus and Its Antiviral Effect[J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(9): 3581-3588.

参考文献

[1] WERNIKE K, EER M.International proficiency trial for Bovine viral diarrhea virus (BVDV) antibody detection:Limitations of milk serology[J].BMC Veterinary Research, 2022, 18(1):168.
[2] KOETHE S, KÖNIG P, WERNIKE K, et al.A synthetic modified live chimeric marker vaccine against BVDV-1 and BVDV-2[J].Vaccines(Basel), 2020, 8(4):577.
[3] SU A, FU Y, MEENS J, et al.Infection of polarized bovine respiratory epithelial cells by Bovine viral diarrhea virus (BVDV)[J]. Virulence, 2021, 12(1):177-187.
[4] DUAN H, MA Z, XU L, et al.A novel intracellularly expressed NS5B specific nano body suppresses Bovine viral diarrhea virus replication[J]. Veterinary Microbiology, 2020, 240:108449.
[5] BUCKLOWD V E, BEER B E, DONIS R O.Bovine viral diarrhea virus as a surrogate model of Hepatitis C virus for the evaluation of antiviral agents[J].Antiviral Research, 2003, 60(1):1-15.
[6] BELLLIDO D, BAZTARRICAA J, ROCHA L, et al.A novel MHCⅡ targeted BVDV subunit vaccine inducesa neutralizing immunological response in guinea pigs and cattle[J].Transboundary and Emerging Diseases, 2021, 68(6):3474-3481.
[7] 张康, 张凯, 王磊, 等.中药抗牛病毒性腹泻病毒研究进展[J].中兽医药杂志, 2019, 38(6):23-26. ZHANG K, ZHANG K, WANG L, et al.Research progress on antibovine viral diarrhea virus in traditional Chinese medicine[J].Chinese Journal of Veterinary Medicine, 2019, 38(6):23-26.(in Chinese)
[8] ZIERCOK A K, MCZKA W K, GRABARCZVK M, et al.Isoxanthohumol——Biologically active hop flavonoid[J].Fitoterapia, 2015, 103:71-82.
[9] 王旭刚.青蒿素抑制黄病毒复制及其机制研究[D].武汉:华中农业大学, 2020. WANG X G.Artemisinin inhibition of Flavivirus replication and its mechanism[D].Wuhan:Huazhong Agricultural University, 2020.(in Chinese)
[10] MUNYANDUKI H, OMAR R, DOUGLASS N, et al.Removal of Bovine viral diarrhea virus (BVDV) from Lumpy skin disease virus (LSDV) vaccine stocks by passage on chorioallantoic membranes of fertilized hens' eggs[J].Journal of Virological Methods, 2020, 275:113752.
[11] 卞娅, 葛广波, 丁侃.中药多糖抗病毒机制研究进展[J].上海中医药大学学报, 2021, 35(5):89-96. BIAN Y, GE G B, DING K. Research progress on the antiviral mechanism of polysaccharides in traditional Chinese medicine[J]. Journal of Shanghai University of Traditional Chinese Medicine, 2021, 35(5):89-96.(in Chinese)
[12] 栗昀.冰香散及其主要成分1, 8-cineol防治流感实验研究[D].广州:广州中医药大学, 2017. LI Y.Experimental study on influenza prevention and control of 1, 8-cineol and its main component[D].Guangzhou:Guangzhou University of Traditional Chinese Medicine, 2017.(in Chinese)
[13] AlKUBATI A A G, HUSSEN J, KANDEEL M, et al.Recent advances on the Bovine viral diarrhea virus molecular pathogenesis, immune response, and vaccines development[J].Frontiers in Veterinary Science, 2021, 14, 8:665128.
[14] 阎祖炜, 朱欣, 李闻文.MTT法、CPE观察法用于药物细胞毒性实验的比较与分析[J].实用预防医学, 2007, 5:1552. YAN Z W, ZHU X, LI W W.Comparison and analysis of MTT method and CPE observation method for drug cytotoxicity experiments[J]. Practical Preventive Medicine, 2007, 5:1552.(in Chinese)
[15] 蔡文涛.MTT法和CCK-8法检测中药抗病毒活性成分细胞毒性的比较[J].湖北大学学报(自然科学版), 2017, 39(3):305-310. CAI W T.Comparison of cytotoxicity of antiviral active ingredients in traditional Chinese medicines by MTT method and CCK-8 method[J].Journal of Hubei University(Natural Science Edition), 2017, 39(3):305-310.(in Chinese)
[16] 徐培平, 赵昉, 刘妮, 等.中药体外防治甲型H1N1流感病毒实验研究[J].实用预防医学, 2012, 19(8):1121-1124. XU P P, ZHAO F, LIU N, et al.In vitro study on preventive effects of three Chinese medicines against Influenza A (H1N1)[J]. Practical Preventive Medicine, 2012, 19(8):1121-1124.(in Chinese)
[17] 雷湘, 陈科力, 杨占秋, 等.大黄素配伍对柯萨奇病毒B3感染小鼠的病毒抑制作用研究[J].中药药理与临床, 2019, 35(1):121-126. LEI X, CHEN K L, YANG Z Q, et al.Viral inhibition effect of emodin compatibility on Coxsackievirus B3 infected mice[J]. Pharmacology and Clinical Practice of Traditional Chinese Medicines, 2019, 35(1):121-126.(in Chinese)
[18] 张春江, 李薇, 孙振鹏, 等.藏药甘青乌头抗单纯疱疹病毒Ⅱ型体内体外作用研究[J].中国医药学杂志., 2009, 44(1):26-31. ZHANG C J, LI W, SUN Z P, et al.Study on the internal and external functions of Tibetan medicine Ganqing Aconitum anti-herpes simplex virus type Ⅱ[J]. Chinese Pharmaceutical Miscellaneous, 2009, 44(1):26-31.(in Chinese)
[19] 杨丽华.藏药甘青乌头中二萜生物碱的研究[D].广州:广东药科大学, 2016. YANG L H.Study on diterpene alkaloids in Tibetan medicine Ganqing Aconitum[D].Guangzhou:Guangdong Pharmaceutical University, 2016.(in Chinese)
[20] 刘璐, 吴立军, 杨春娟.紫堇属植物中异喹啉类生物碱的化学结构和生物活性的研究进展[J].实用药物与临床, 2016, 19(3):371-380. LIU L, WU L J, YANG C J.Research progress on chemical structure and biological activity of is oquinoline alkaloids in violet[J].Practical Drugs and Clinical Medicines, 2016, 19(3):371-380.(in Chinese)
[21] SILVIA M, ALESSANDRA M, GIUSEPPINA S, et al.Bovine viral diarrhea virus (BVDV):A preliminary study on antiviral properties of some aromatic and medicinal plants[J] .Pathogens, 2021, 10(4):403.
[22] 王慧, 杜锐, 周红潮, 等.中药抗牛病毒性腹泻病毒作用研究现状[J].动物医学进展, 2018, 39(2):123-126. WANG H, DU R, ZHOU H C, et al.Research status of antibovine viral diarrhea virus in traditional Chinese medicine[J].Advancesin Veterinary Medicine, 2018, 39(2):123-126.(in Chinese)
[23] HUANG K, ZHANG P, ZHANG Z H, et al.Traditional Chinese medicine (TCM) in the treatment of viral infections:Efficacies and mechanisms[J].Pharmacology & Therapeutics, 2021, 225:107843.